Purpose Recent reports have described a spectrum of uncommon findings of intraocular
inflammation (IOI), retinal vasculitis and/or retinal vascular occlusion in patients with …

Intravitreal injections (IVI) have become the most common intraocular procedure worldwide
with increasing numbers every year. The article presents the most up-to-date review on IVI …

Introduction: Investigational anti-VEGF treatments for neovascular age-related macular
degeneration (nAMD) aim to improve visual outcomes and reduce treatment burden; these …

Intravitreal injections continue to be one of the most commonly performed procedures by
ophthalmologists. Although the injections are generally well tolerated, sight-threatening …

Purpose: To investigate the safety of face masks worn by patients during intravitreal
injections. Methods: A prospective, qualitative, interventional study performed in a tertiary …

Purpose: Brolucizumab has high efficacy in retinal fluid resolution and provides the
possibility for longer dosing intervals in the treatment of neovascular age-related macular …

Introduction: Evolving anti-vascular endothelial growth factor (VEGF) treatments for
neovascular age-related macular degeneration (nAMD) include long acting agents …

Importance The number of patients affected by retinal diseases treated with intravitreal
injections (IVTs) has resulted in a rapidly growing number of procedures. One of the worst …

Introduction Age-related macular degeneration (AMD) is the leading cause of irreversible
blindness among people age 60 years or older in developed countries. Current standard-of …

Purpose To report the rate, risk factors, and outcomes of rhegmatogenous retinal
detachment (RRD) after intravitreal injection of anti–vascular endothelial growth factor …